Press Release

View printer-friendly version << Back

vTv Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

PDF Version

HIGH POINT, N.C.--(BUSINESS WIRE)--Jul. 6, 2016-- vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, today announced that Company management will present a corporate overview at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Wednesday, July 13, 2016 at 8:00 a.m. ET in New York City.

A live webcast of the presentation can be accessed on the News & Events section of the website. The webcast will be archived for 30 days following the presentation on the company website at www.vtvtherapeutics.com.

About vTv Therapeutics

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and Type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.

Source: vTv Therapeutics Inc.

Investors
The Trout Group
Michael Gibralter, 646-378- 2938
mgibralter@troutgroup.com
or
Media
BMC Communications
Brad Miles, 646-513- 3125
bmiles@bmccommunications.com